| 2AO6 
   
  | | Crystal structure of the human androgen receptor ligand binding domain bound with TIF2(iii) 740-753 peptide and R1881 |  | Descriptor: | (17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE, 14-mer fragment of Nuclear receptor coactivator 2, androgen receptor |  | Authors: | He, B,  Gampe Jr,  R.T,  Kole, A.J,  Hnat, A.T,  Stanley, T.B,  An, G,  Stewart, E.L,  Kalman, R.I,  Minges, J.T,  Wilson, E.M. |  | Deposit date: | 2005-08-12 |  | Release date: | 2005-08-30 |  | Last modified: | 2023-08-23 |  | Method: | X-RAY DIFFRACTION (1.89 Å) |  | Cite: | Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance Mol.Cell, 16, 2004
 
 | 
 | 
| 1XOW 
   
  | | Crystal structure of the human androgen receptor ligand binding domain bound with an androgen receptor NH2-terminal peptide, AR20-30, and R1881 |  | Descriptor: | (17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE, androgen receptor, decamer fragment of androgen receptor |  | Authors: | He, B,  Gampe Jr,  R.T,  Kole, A.J,  Hnat, A.T,  Stanley, T.B,  An, G,  Stewart, E.L,  Kalman, R.I,  Minges, J.T,  Wilson, E.M. |  | Deposit date: | 2004-10-07 |  | Release date: | 2004-11-16 |  | Last modified: | 2023-08-23 |  | Method: | X-RAY DIFFRACTION (1.8 Å) |  | Cite: | Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance Mol.Cell, 16, 2004
 
 | 
 | 
| 1XQ3 
   
  | | Crystal structure of the human androgen receptor ligand binding domain bound with R1881 |  | Descriptor: | (17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE, androgen receptor |  | Authors: | He, B,  Gampe Jr,  R.T,  Kole, A.J,  Hnat, A.T,  Stanley, T.B,  An, G,  Stewart, E.L,  Kalman, R.I,  Minges, J.T,  Wilson, E.M. |  | Deposit date: | 2004-10-11 |  | Release date: | 2004-11-16 |  | Last modified: | 2023-08-23 |  | Method: | X-RAY DIFFRACTION (2.25 Å) |  | Cite: | Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance Mol.Cell, 16, 2004
 
 | 
 |